Wilms' tumor screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Wilms' tumor}}
{{Wilms' tumor}}
{{CMG}}; {{AE}} {{SC}}
{{CMG}}; {{AE}} {{SSW}}


==Overview==
==Overview==

Latest revision as of 20:05, 31 May 2018

Wilms' tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Wilms' Tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography or Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Wilms' tumor screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Wilms' tumor screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Wilms' tumor screening

CDC on Wilms' tumor screening

Wilms' tumor screening in the news

Blogs on Wilms' tumor screening

Directions to Hospitals Treating Wilms' tumor

Risk calculators and risk factors for Wilms' tumor screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2]

Overview

Screening can be very helpful to diagnose wilms tumor in high risk patients.Screening is done with serial abdominal ultrasonography.

Screening

  • Screening can be very helpful to diagnose wilms tumor in high risk patients.[1]
  • High risk patients include:
  • Screening is done with serial abdominal ultrasonography.[2]
  • Serial abdominal ultrasonography is done as follows:
    • Children suffering from beckwith-wiedemann syndrome:
      • Ultrasonography every three months until age seven years.
    • Children suffering with WAGR and WT1-related syndromes:
      • Ultrasonography every three months until age five years
    • Siblings of an individual with familial wilms tumor:
      • Ultrasonography every three months until age eight years.
    • Offspring of survivors of bilateral wilms tumor:
      • Ultrasonography every three months until age eight years.

References

  1. Green DM, Breslow NE, Beckwith JB, Norkool P (1993). "Screening of children with hemihypertrophy, aniridia, and Beckwith-Wiedemann syndrome in patients with Wilms tumor: a report from the National Wilms Tumor Study". Med. Pediatr. Oncol. 21 (3): 188–92. PMID 8095320.
  2. Kalish JM, Doros L, Helman LJ, Hennekam RC, Kuiper RP, Maas SM, Maher ER, Nichols KE, Plon SE, Porter CC, Rednam S, Schultz K, States LJ, Tomlinson GE, Zelley K, Druley TE (July 2017). "Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and Hepatoblastoma". Clin. Cancer Res. 23 (13): e115–e122. doi:10.1158/1078-0432.CCR-17-0710. PMID 28674120. Vancouver style error: initials (help)

Template:WH Template:WS